| Intercell Announces Initial Results Of Phase IIl Trial Evaluating V710, An ... - Medical News Today (press release) |
|
| Medical News Today (press release)"It is very encouraging to see that the S. aureus vaccine has proven immunogenic and was generally well tolerated in ESRD patients receiving hemodialysis. |